News

TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer

Debora Barton Debora BartonWALTHAM, Mass., July 07, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company…

2 years ago

XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)

CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…

2 years ago

Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

SEATTLE and CAMBRIDGE, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company…

2 years ago

BioAdaptives, Inc. Introduces PrimiSleep™, An Advanced Sleep-Aid Designed to Harmonize with the Body’s Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No “Hangover”

PrimiSleep™ Enters Rapidly Growing Global Sleep Aid Market With State-of-the-Art Supplement LAS VEGAS, NV, July 07, 2022 (GLOBE NEWSWIRE) --…

2 years ago

EvolveImmune Therapeutics Appoints Jay Fine, Ph.D., as President of Research and Development

Over 30 Years of Leadership in Drug Discovery and Development, Translational Sciences and Biomarker Research in Immunology, Inflammatory Diseases and…

2 years ago

MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers

EscharEx Showed Safe, Effective and Rapid Debridement in VLUs and DFUsData Demonstrates EscharEx Reduced Wound Size, Biofilm and Bacterial Burden…

2 years ago

Zynerba Pharmaceuticals Announces Panel Presentation and Poster Presentations at the NFXF International Fragile X Conference

DEVON, Pa., July 07, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid…

2 years ago

RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results

-- Expects second quarter 2022 preliminary UPNEEQ net product sales of approximately $8.4 million, representing an increase of 42% from…

2 years ago

Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen

This becomes the 6th Senhance Hospital in GermanyRESEARCH TRIANGLE PARK, N.C., July 07, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc.…

2 years ago

ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022

PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…

2 years ago